RRC 10-Q report for 2025-06-30
Range Resources Corporation filed its Form 10‑Q for the quarter ended June 30, 2025. The filing includes consolidated financial statements (balance sheet, statements of income, comprehensive income, cash flows and stockholders’ equity), notes, and MD&A. Reported highlights in the filing include total assets of $7,105,111 (thousands), Q2 2025 net income of $237,578 (thousands), and cash and cash equivalents of $134 (thousands). Outcome: failed. Recommended action: sell. Status: expired.
Linked assets
RRC — Range Resources Corporation. The filing covers the quarter ended June 30, 2025 and provides full consolidated financial statements and MD&A for the period.
Range Resources Corporation (RRC) Form 10‑Q for the quarter ended June 30, 2025 — includes consolidated financial statements, notes and MD&A.
The Form 10‑Q provides a full set of unaudited consolidated financial statements and disclosures for the quarter ended June 30, 2025. Reported highlights in the filing include: cash and cash equivalents of $134 (thousands), total assets $7,105,111 (thousands), total liabilities $2,978,417 (thousands), total stockholders’ equity $4,126,694 (thousands), three months ended June 30, 2025 revenues and other income of $856,275 (thousands) and net income of $237,578 (thousands). The filing includes the balance sheet, statements of income, comprehensive income, cash flows and stockholders’ equity, plus notes and MD&A references. Based on the provided filing content, the play outcome is labeled 'failed' and the recommended strategy 'sell'. This play is expired. Note: the filing should be reviewed in full (including MD&A and notes) before taking any position; the play reflects the filing’s reported results and the stated recommendation but does not assert a performance guarantee.
Source proof
Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review
Primary source: Range Resources Corporation Form 10‑Q for the quarter ended June 30, 2025 (SEC filing). The included financial statements (unaudited) in the filing: Consolidated Balance Sheets; Consolidated Statements of Income; Consolidated Statements of Comprehensive Income; Consolidated Statements of Cash Flows; Consolidated Statements of Stockholders’ Equity; and accompanying Notes. Key reported line items shown in the filing include cash and cash equivalents $134; total assets $7,105,111; total liabilities $2,978,417; total stockholders’ equity $4,126,694; three months ended June 30, 2025 revenues and other income $856,275 and net income $237,578. The filing also lists sections for MD&A, market risk disclosures, controls and procedures, risk factors and exhibits.
This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.
The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic 'company filed its 10‑Q' metadata.
The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).
This excerpt is only the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.
This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.
This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.
This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.
The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.
Supporting authors
1 author supplied metadata for this play. Related filings and cover-page excerpts from other 10‑Q filings were reviewed but are ancillary and not materially actionable on their own.
Unlock full thesis monitoring
Read the full Form 10‑Q in the SEC EDGAR system for complete disclosures, notes and exhibits. Use the financial statements and MD&A to update models, assess cash and liquidity movements, and evaluate leverage and capital allocation before acting on the sell recommendation.